Safety study of Pharmacokinetics, Safety, and Tolerability of ABBV-932 in anxiety
This study is completed in the United States. It is testing Pharmacokinetics, Safety, and Tolerability of ABBV-932 for anxiety.
In United States
Compare studies and check their requirements with the research team.
This study is completed in the United States. It is testing Pharmacokinetics, Safety, and Tolerability of ABBV-932 for anxiety.
In United StatesThis study was terminated in the United States. It focuses on Suicide prevention.
In United StatesThis study is completed in the United States, in the United Kingdom, in Germany, .... It is testing Safety and Efficacy of BIIB104 for schizophrenia.
In United StatesThis study is completed in the United States, in Belgium, and in Japan. It is testing safety and Efficacy of Intranasal Esketamine for treatment-resistant depression.
In United StatesThis study was terminated in the United States. It is testing Safety And Efficacy Of PF-04958242 for schizophrenia.
In United StatesThis study is completed in the United States, in Belgium, in Germany, .... It is testing safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation for Schizophrenia.
In United StatesThis study is completed in the United States. It is testing Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine for schizophrenia.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is completed in the United States. It is testing PF-02545920 for schizophrenia.
In United StatesThis study is completed in the United States. It is testing PF-04958242 for schizophrenia.
In United StatesThis study is completed in the United States. It focuses on depression.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.